Page 20 - Pfizer

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

Nifty outlook and stock picks by Sameet Chavan: Buy Balrampur Chini, Pfizer

The deciding factor in days to come has to be the financial space

Pfizer asks US FDA to clear its coronavirus vaccine for use in kids

Pfizer and BioNTech have asked the US Food and Drug Administration (FDA) to expand the Emergency Use Authorization (EUA) for its Covid-19 vaccine to include children ages 12 to 15.

Pfizer asks US government to allow more kids to get Covid-19 vaccine

Drug giant Pfizer and its partner in developing the first COVID-19 vaccine that received emergency authorisation in the US want to allow more adolescents to receive the vaccine

Australia backs Pfizer virus vaccine over AstraZeneca for under-50s

Australia's Chief Medical Officer, Paul Kelly, told reporters the risk of clots was extremely low.

US begins study assessing allergic reactions to Pfizer, Moderna vaccines

Data from the study, which is sponsored and funded by the NIAID, is expected to be released in late summer

France imposes third lockdown amid rising Covid-19 cases, schools closed

The French leader implored the nation to make an extra effort as the lockdown comes into force on Saturday

Supply chain threats

Vaccine nationalism shows how the pandemic has stressed trade

Pfizer says its Covid-19 vaccine protects younger teens

Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group

Top headlines: PLI for food processing; RBI relief for auto-debit payments

Business Standard brings you top news of the day

BioNTech-Pfizer says its Covid-19 vaccine effective on 12-15 year olds

In a study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots

BioNTech-Pfizer raise 2021 Covid-19 vaccine output goal to 2.5 bn doses

Pfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021

At $2.06 per dose, India pays the least for AstraZeneca Covid-19 vaccine

The price paid by different governments for a vaccine dose - including for the same vaccine - varies across countries, Unicef data shows

Pfizer, BioNTech launch Covid-19 vaccine trial in kids under 12

(Reuters) - Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S. drugmaker said on Thursday.

Pfizer begins Phase 1 clinical trial of oral pill to treat Covid-19

US pharmaceutical company Pfizer has begun Phase 1 clinical trial of a novel oral antiviral drug for SARS-CoV-2, the virus that causes Covid-19

Hong Kong suspends Pfizer-BioNTech Covid vaccines over packaging defects

Hong Kong suspended vaccinations using Pfizer shots known as BioNTech shots in the city on Wednesday after they were informed by its distributor Fosun that one batch had defective bottle lids

Pfizer vaccine production on the rise as pandemic hits one-year mark

By the fourth quarter of this year, Pfizer and BioNTech will reach a 3 billion dose a year production run rate, and should be able to produce that much next year, Pfizer Chief Executive said

Pfizer vaccine 97% effective against symptomatic Covid: Study

The analysis also shows real-world evidence of the vaccine's effectiveness against a highly infectious variant of COVID-19 first discovered in Britain, known as B.1.1.7

No plan to manufacture Covid-19 vaccine in India during pandemic: Pfizer

Company was the first vaccine maker to apply for an emergency-use authorisation in India.